RxDoctor Payments Data

Lauren Hornsby, NP

Family · Carrollton, GANPI 1972932036

Payments from drug & device makers

$1,894in general payments, 2019–2025

Across 101 payments — averaging $18.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$593
  • Teva Pharmaceuticals USA, Inc.$288
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$265
  • Alkermes, Inc.$151
  • Neurocrine Biosciences, Inc.$111
  • Axsome Therapeutics, Inc.$107
  • plus $379 from 5 others

What the payments were for

  • Food & beverage$1,67989%
  • Education$21511%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,894 in reported general payments places this provider in the 75th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Medicare billing

Part B allowed, 2024
$8,232
Medicare patients
14
Services billed
95

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine34$317,951
Invega SustennaPaliperidone Palmitate13$32,244
RexultiBrexpiprazole15$22,298
TrintellixVortioxetine Hydrobromide19$12,819
Lurasidone Hcl44$7,084
Vilazodone Hcl32$3,437
Paliperidone ErPaliperidone12$1,813
AmantadineAmantadine Hcl30$1,365
Doxepin Hcl22$599
Lamotrigine97$536
Haloperidol Decanoate14$509
Prazosin Hcl32$496
Gabapentin27$413
Buspirone Hcl46$404
Olanzapine28$376

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$288$317,95134 claims
Johnson & JohnsonInvega Sustenna$72$32,24413 claims
Otsuka America Pharmaceutical, Inc.Rexulti$80$22,29815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,258 family providers in Georgia.

Other family in Carrollton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →